Lista de obras -

A multi-institutional validation of the prognostic value of the neutrophil-to-lymphocyte ratio for upper tract urothelial carcinoma treated with radical nephroureterectomy

scientific article published on 10 June 2014

Acquired platinum resistance involves epithelial to mesenchymal transition through ubiquitin ligase FBXO32 dysregulation

artículo científico publicado en 2016

Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration.

artículo científico publicado en 2009

Angiotensin II type 1 receptor expression and microvessel density in human bladder cancer

artículo científico publicado en 2011

Appropriate timing for a biochemical evaluation after adrenalectomy for unilateral aldosterone-producing adenoma

artículo científico publicado en 2020

Are the Formulas Used to Estimate Renal Function Adequate for Patients Treated With Cisplatin-Based Chemotherapy After Nephroureterectomy for Upper Tract Urothelial Carcinoma?

artículo científico publicado en 2016

BCG-induced cytokine release in bladder cancer cells is regulated by Ca signaling

scientific article published on 13 December 2018

Bisebromoamide, an extract from Lyngbya species, induces apoptosis through ERK and mTOR inhibitions in renal cancer cells

artículo científico publicado en 2013

C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy

artículo científico publicado en 2012

Can random bladder biopsies be eliminated after bacillus Calmette-Guérin therapy against carcinoma in situ?

artículo científico publicado en 2020

Cis-dichlorodiammineplatinum upregulates angiotensin II type 1 receptors through reactive oxygen species generation and enhances VEGF production in bladder cancer.

artículo científico publicado en 2010

Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases.

artículo científico publicado en 2009

Down-regulation of NF kappa B activation is an effective therapeutic modality in acquired platinum-resistant bladder cancer

artículo científico publicado en 2015

Effect of a novel nuclear factor-κB activation inhibitor on renal ischemia-reperfusion injury.

artículo científico publicado en 2013

Effect of reclassification of the IMDC model in patients with metastatic renal cell carcinoma treated with targeted therapy in the first-line and second-line settings

artículo científico publicado en 2016

Evaluating the Oncological Outcomes of Pure Laparoscopic Radical Nephroureterectomy Performed for Upper-Tract Urothelial Carcinoma Patients: A Multicenter Cohort Study Adjusted by Propensity Score Matching

artículo científico publicado en 2020

Evaluation of Gleason Grade Group 5 in a Contemporary Prostate Cancer Grading System and Literature Review

scientific article published on 07 August 2020

Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study.

artículo científico publicado en 2008

External Validation of the MSKCC and IMDC Risk Models in Patients Treated with Targeted Therapy as a First-line and Subsequent Second-line Treatment: A Japanese Multi-institutional Study

artículo científico publicado en 2015

External validation of the "optimal PSA follow-up schedule after radical prostatectomy" in a new cohort

scientific article published on 13 April 2020

Factors affecting renal function preservation among patients not achieving trifecta after laparoscopic partial nephrectomy for clinical T1a renal masses

scientific article published on 09 December 2019

Frequency of tumor recurrence: a strong predictor of stage progression in initially diagnosed nonmuscle invasive bladder cancer

artículo científico publicado en 2010

Germline Whole-Gene Deletion of FH Diagnosed from Tumor Profiling ⬇️

artículo científico

History of Non-Muscle-Invasive Bladder Cancer May Have a Worse Prognostic Impact in cT2-4aN0M0 Bladder Cancer Patients Treated With Radical Cystectomy

scientific article published on 28 April 2018

Impact of Combined Use of Blood-based Inflammatory Markers on Patients with Upper Tract Urothelial Carcinoma Following Radical Nephroureterectomy: Proposal of a Cumulative Marker Score as a Novel Predictive Tool for Prognosis

artículo científico publicado en 2015

Impact of Second-Line Targeted Therapy Dose Intensity on Patients With Metastatic Renal Cell Carcinoma

artículo científico publicado en 2016

Impact of an adjuvant chemotherapeutic regimen on the clinical outcome in high risk patients with upper tract urothelial carcinoma: a Japanese multi-institution experience

artículo científico publicado en 2014

Impact of inflammatory marker levels one month after the first-line targeted therapy initiation on progression-free survival prediction in patients with metastatic clear cell renal cell carcinoma

artículo científico publicado en 2019

Impact of smoking status on bladder tumor recurrence after radical nephroureterectomy for upper tract urothelial carcinoma.

artículo científico publicado en 2013

Independent predictors for bladder outcomes after treatment of intravesical recurrence following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma

artículo científico publicado en 2014

Landscape of genomic alterations of circulating tumor DNA in advanced genitourinary cancer patients: SCRUM-Japan MONSTAR SCREEN Project

artículo científico publicado en 2021

Late recurrence and progression in non-muscle-invasive bladder cancers after 5-year tumor-free periods

scientific article published on 29 January 2010

Long term follow-up in patients with initially diagnosed low grade Ta non-muscle invasive bladder tumors: tumor recurrence and worsening progression.

artículo científico publicado en 2014

Low‐dose docetaxel enhances the sensitivity of S‐1 in a xenograft model of human castration resistant prostate cancer ⬇️

artículo científico publicado el 25 de abril de 2011

Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma.

artículo científico publicado en 2008

MP36-07 EVALUATING THE DIAGNOSTIC ACCURACY OF VESICAL IMAGING-REPORTING AND DATA SYSTEM FOR DETECTING MUSCLE-INVASIVE BLADDER CANCER IN REAL CLINICAL SETTING

artículo científico publicado en 2020

Metastatic behavior of upper tract urothelial carcinoma after radical nephroureterectomy: association with primary tumor location.

artículo científico publicado en 2013

Nicotine Induces Tumor Growth and Chemoresistance through Activation of the PI3K/Akt/mTOR Pathway in Bladder Cancer.

artículo científico publicado en 2015

Optimal timing of hormonal therapy for prostate-specific antigen recurrence after radical prostatectomy

artículo científico publicado en 2014

Overall survival of first-line axitinib in metastatic renal cell carcinoma: Japanese subgroup analysis from phase II study

artículo científico publicado en 2017

PS3-2 Genomic characterization of circulating tumor DNA in advanced genitourinary cancer patients SCRUM-Japan MONSTAR SCREEN

Patient age was an independent predictor of cancer-specific survival in male patients with upper tract urothelial carcinoma treated by radical nephroureterectomy

artículo científico publicado en 2016

Patient characteristics and outcomes in metastatic upper tract urothelial carcinoma after radical nephroureterectomy: the experience of Japanese multi-institutions.

artículo científico publicado en 2013

Plasma fibrinogen level: an independent prognostic factor for disease-free survival and cancer-specific survival in patients with localised renal cell carcinoma.

artículo científico publicado en 2016

Potent cytotoxic effect of a novel nuclear factor-kappaB inhibitor dehydroxymethylepoxyquinomicin on human bladder cancer cells producing various cytokines.

artículo científico publicado en 2010

Preoperative hydronephrosis grade independently predicts worse pathological outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma

scientific article published on 21 March 2011

Preoperative hydronephrosis: independent predictor for changes in renal function following nephroureterectomy

artículo científico publicado en 2012

Profiling the inhibitory receptors LAG-3, TIM-3, and TIGIT in renal cell carcinoma reveals malignancy

artículo científico publicado en 2021

Prognostic Impact of Renin-Angiotensin System Blockade on Renal Cell Carcinoma After Surgery.

artículo científico publicado en 2015

Prognostic significance of Bacillus Calmette-Guérin failure classification in non-muscle-invasive bladder cancer

artículo científico publicado en 2012

Prognostic significance of high nuclear grade in patients with pathologic T1a renal cell carcinoma

artículo científico publicado en 2012

Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic renal cell carcinoma treated with first-line and subsequent second-line targeted therapy: A proposal of the modified-IMDC risk model

artículo científico publicado en 2016

Prognostic value of plasma fibrinogen levels in patients with localized upper tract urothelial carcinoma.

artículo científico publicado en 2012

Prognostic value of renin-angiotensin system blockade in non-muscle-invasive bladder cancer.

artículo científico publicado en 2012

Prognostic value of serum C-reactive protein level prior to second-line treatment in intermediate risk metastatic renal cell carcinoma patients

scientific article published on 07 May 2019

Refraining from Smoking for 15 Years or More Reduced the Risk of Tumor Recurrence in Non-muscle Invasive Bladder Cancer Patients.

artículo científico publicado en 2015

Regulation of human dendritic cells by a novel specific nuclear factor-kappaB inhibitor, dehydroxymethylepoxyquinomicin

artículo científico publicado en 2010

Regulation of monocyte chemoattractant protein-1 through angiotensin II type 1 receptor in prostate cancer.

artículo científico publicado en 2012

Relationship Between Increased Expression of the Axl/Gas6 Signal Cascade and Prognosis of Patients with Upper Tract Urothelial Carcinoma.

artículo científico publicado en 2015

Renal cell carcinoma arising from a horseshoe kidney in a chronic hemodialysis patient.

artículo científico publicado en 2012

Risk of subsequent tumour recurrence and stage progression in bacille Calmette-Guérin relapsing non-muscle-invasive bladder cancer

artículo científico publicado en 2012

Role of the MUC1-C Oncoprotein in the Acquisition of Cisplatin Resistance by Urothelial Carcinoma

artículo científico publicado en 2020

Significance of a frozen section analysis of the ureteral margin in bladder cancer patients treated with radical cystectomy and neoadjuvant chemotherapy.

artículo científico publicado en 2017

Significance of tumor microenvironment in acquiring resistance to vascular endothelial growth factor-tyrosine kinase inhibitor and recent advance of systemic treatment of clear cell renal cell carcinoma

scientific article published on 11 July 2020

Sub-classification of patients with intermediate-risk metastatic renal cell carcinoma treated with targeted therapy

scientific article published on 01 August 2019

The Clinicopathological Characteristics of Muscle-Invasive Bladder Recurrence in Upper Tract Urothelial Carcinoma

scientific article published on 25 December 2020

The implications of prostate-specific antigen density to predict clinically significant prostate cancer in men ≤ 50 years

artículo científico publicado en 2014

The novel NF-kappaB activation inhibitor dehydroxymethyl-epoxyquinomicin suppresses anti-Thy1.1-induced glomerulonephritis in rats

artículo científico publicado en 2008

The predictive value of C-reactive protein for prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: a multi-institutional study

artículo científico publicado en 2012

The predictive value of positive urine cytology for outcomes following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma: a multi-institutional study

scientific article published on 18 September 2013

The prognostic significance of vasohibin-1 expression in patients with upper urinary tract urothelial carcinoma

artículo científico publicado en 2012

The prognostic value of zonal origin and extraprostatic extension of prostate cancer for biochemical recurrence after radical prostatectomy

artículo científico publicado en 2019

Three cases of granulocyte colony-stimulating factor-producing urinary upper tract carcinomas

artículo científico publicado en 2012

Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract.

artículo científico publicado en 2009

Type of patients in whom biochemical recurrence after radical prostatectomy can be observed without salvage therapy

scientific article published on 26 September 2019

Variant isoforms of CD44 involves acquisition of chemoresistance to cisplatin and has potential as a novel indicator for identifying a cisplatin-resistant population in urothelial cancer.

artículo científico publicado en 2018

Lista de obras de

A multi-institutional validation of the prognostic value of the neutrophil-to-lymphocyte ratio for upper tract urothelial carcinoma treated with radical nephroureterectomy

Acquired platinum resistance involves epithelial to mesenchymal transition through ubiquitin ligase FBXO32 dysregulation

Adjuvant chemotherapy for high risk upper tract urothelial carcinoma: results from the Upper Tract Urothelial Carcinoma Collaboration.

Angiotensin II type 1 receptor expression and microvessel density in human bladder cancer

Appropriate timing for a biochemical evaluation after adrenalectomy for unilateral aldosterone-producing adenoma

Are the Formulas Used to Estimate Renal Function Adequate for Patients Treated With Cisplatin-Based Chemotherapy After Nephroureterectomy for Upper Tract Urothelial Carcinoma?

BCG-induced cytokine release in bladder cancer cells is regulated by Ca signaling

Bisebromoamide, an extract from Lyngbya species, induces apoptosis through ERK and mTOR inhibitions in renal cancer cells

C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy

Can random bladder biopsies be eliminated after bacillus Calmette-Guérin therapy against carcinoma in situ?

Cis-dichlorodiammineplatinum upregulates angiotensin II type 1 receptors through reactive oxygen species generation and enhances VEGF production in bladder cancer.

Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases.

Down-regulation of NF kappa B activation is an effective therapeutic modality in acquired platinum-resistant bladder cancer

Effect of a novel nuclear factor-κB activation inhibitor on renal ischemia-reperfusion injury.

Effect of reclassification of the IMDC model in patients with metastatic renal cell carcinoma treated with targeted therapy in the first-line and second-line settings

Evaluating the Oncological Outcomes of Pure Laparoscopic Radical Nephroureterectomy Performed for Upper-Tract Urothelial Carcinoma Patients: A Multicenter Cohort Study Adjusted by Propensity Score Matching

Evaluation of Gleason Grade Group 5 in a Contemporary Prostate Cancer Grading System and Literature Review

Evidence-based sex-related outcomes after radical nephroureterectomy for upper tract urothelial carcinoma: results of large multicenter study.

External Validation of the MSKCC and IMDC Risk Models in Patients Treated with Targeted Therapy as a First-line and Subsequent Second-line Treatment: A Japanese Multi-institutional Study

External validation of the "optimal PSA follow-up schedule after radical prostatectomy" in a new cohort

Factors affecting renal function preservation among patients not achieving trifecta after laparoscopic partial nephrectomy for clinical T1a renal masses

Frequency of tumor recurrence: a strong predictor of stage progression in initially diagnosed nonmuscle invasive bladder cancer

Germline Whole-Gene Deletion of FH Diagnosed from Tumor Profiling ⬇️

History of Non-Muscle-Invasive Bladder Cancer May Have a Worse Prognostic Impact in cT2-4aN0M0 Bladder Cancer Patients Treated With Radical Cystectomy

Impact of Combined Use of Blood-based Inflammatory Markers on Patients with Upper Tract Urothelial Carcinoma Following Radical Nephroureterectomy: Proposal of a Cumulative Marker Score as a Novel Predictive Tool for Prognosis

Impact of Second-Line Targeted Therapy Dose Intensity on Patients With Metastatic Renal Cell Carcinoma

Impact of an adjuvant chemotherapeutic regimen on the clinical outcome in high risk patients with upper tract urothelial carcinoma: a Japanese multi-institution experience

Impact of inflammatory marker levels one month after the first-line targeted therapy initiation on progression-free survival prediction in patients with metastatic clear cell renal cell carcinoma

Impact of smoking status on bladder tumor recurrence after radical nephroureterectomy for upper tract urothelial carcinoma.

Independent predictors for bladder outcomes after treatment of intravesical recurrence following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma

Landscape of genomic alterations of circulating tumor DNA in advanced genitourinary cancer patients: SCRUM-Japan MONSTAR SCREEN Project

Late recurrence and progression in non-muscle-invasive bladder cancers after 5-year tumor-free periods

Long term follow-up in patients with initially diagnosed low grade Ta non-muscle invasive bladder tumors: tumor recurrence and worsening progression.

Low‐dose docetaxel enhances the sensitivity of S‐1 in a xenograft model of human castration resistant prostate cancer ⬇️

Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma.

MP36-07 EVALUATING THE DIAGNOSTIC ACCURACY OF VESICAL IMAGING-REPORTING AND DATA SYSTEM FOR DETECTING MUSCLE-INVASIVE BLADDER CANCER IN REAL CLINICAL SETTING

Metastatic behavior of upper tract urothelial carcinoma after radical nephroureterectomy: association with primary tumor location.

Nicotine Induces Tumor Growth and Chemoresistance through Activation of the PI3K/Akt/mTOR Pathway in Bladder Cancer.

Optimal timing of hormonal therapy for prostate-specific antigen recurrence after radical prostatectomy

Overall survival of first-line axitinib in metastatic renal cell carcinoma: Japanese subgroup analysis from phase II study

PS3-2 Genomic characterization of circulating tumor DNA in advanced genitourinary cancer patients SCRUM-Japan MONSTAR SCREEN

Patient age was an independent predictor of cancer-specific survival in male patients with upper tract urothelial carcinoma treated by radical nephroureterectomy

Patient characteristics and outcomes in metastatic upper tract urothelial carcinoma after radical nephroureterectomy: the experience of Japanese multi-institutions.

Plasma fibrinogen level: an independent prognostic factor for disease-free survival and cancer-specific survival in patients with localised renal cell carcinoma.

Potent cytotoxic effect of a novel nuclear factor-kappaB inhibitor dehydroxymethylepoxyquinomicin on human bladder cancer cells producing various cytokines.

Preoperative hydronephrosis grade independently predicts worse pathological outcomes in patients undergoing nephroureterectomy for upper tract urothelial carcinoma

Preoperative hydronephrosis: independent predictor for changes in renal function following nephroureterectomy

Profiling the inhibitory receptors LAG-3, TIM-3, and TIGIT in renal cell carcinoma reveals malignancy

Prognostic Impact of Renin-Angiotensin System Blockade on Renal Cell Carcinoma After Surgery.

Prognostic significance of Bacillus Calmette-Guérin failure classification in non-muscle-invasive bladder cancer

Prognostic significance of high nuclear grade in patients with pathologic T1a renal cell carcinoma

Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic renal cell carcinoma treated with first-line and subsequent second-line targeted therapy: A proposal of the modified-IMDC risk model

Prognostic value of plasma fibrinogen levels in patients with localized upper tract urothelial carcinoma.

Prognostic value of renin-angiotensin system blockade in non-muscle-invasive bladder cancer.

Prognostic value of serum C-reactive protein level prior to second-line treatment in intermediate risk metastatic renal cell carcinoma patients

Refraining from Smoking for 15 Years or More Reduced the Risk of Tumor Recurrence in Non-muscle Invasive Bladder Cancer Patients.

Regulation of human dendritic cells by a novel specific nuclear factor-kappaB inhibitor, dehydroxymethylepoxyquinomicin

Regulation of monocyte chemoattractant protein-1 through angiotensin II type 1 receptor in prostate cancer.

Relationship Between Increased Expression of the Axl/Gas6 Signal Cascade and Prognosis of Patients with Upper Tract Urothelial Carcinoma.

Renal cell carcinoma arising from a horseshoe kidney in a chronic hemodialysis patient.

Risk of subsequent tumour recurrence and stage progression in bacille Calmette-Guérin relapsing non-muscle-invasive bladder cancer

Role of the MUC1-C Oncoprotein in the Acquisition of Cisplatin Resistance by Urothelial Carcinoma

Significance of a frozen section analysis of the ureteral margin in bladder cancer patients treated with radical cystectomy and neoadjuvant chemotherapy.

Significance of tumor microenvironment in acquiring resistance to vascular endothelial growth factor-tyrosine kinase inhibitor and recent advance of systemic treatment of clear cell renal cell carcinoma

Sub-classification of patients with intermediate-risk metastatic renal cell carcinoma treated with targeted therapy

The Clinicopathological Characteristics of Muscle-Invasive Bladder Recurrence in Upper Tract Urothelial Carcinoma

The implications of prostate-specific antigen density to predict clinically significant prostate cancer in men ≤ 50 years

The novel NF-kappaB activation inhibitor dehydroxymethyl-epoxyquinomicin suppresses anti-Thy1.1-induced glomerulonephritis in rats

The predictive value of C-reactive protein for prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy: a multi-institutional study

The predictive value of positive urine cytology for outcomes following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma: a multi-institutional study

The prognostic significance of vasohibin-1 expression in patients with upper urinary tract urothelial carcinoma

The prognostic value of zonal origin and extraprostatic extension of prostate cancer for biochemical recurrence after radical prostatectomy

Three cases of granulocyte colony-stimulating factor-producing urinary upper tract carcinomas

Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract.

Type of patients in whom biochemical recurrence after radical prostatectomy can be observed without salvage therapy

Variant isoforms of CD44 involves acquisition of chemoresistance to cisplatin and has potential as a novel indicator for identifying a cisplatin-resistant population in urothelial cancer.